Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1991 | 09-1991 | 06-1991 | 03-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,186 | 17,278 | 19,029 | 20,460 | 15,489 |
| Marketable Securities | 5,003 | 691 | 649 | 499 | 761 |
| Receivables | 943 | 1,318 | 1,684 | 1,030 | 1,278 |
| Inventories | 1,172 | 1,184 | 1,106 | 1,037 | 969 |
| Other current assets | 186 | 74 | 344 | 243 | 268 |
| TOTAL | $20,489 | $20,545 | $22,812 | $23,268 | $18,765 |
| Non-Current Assets | |||||
| PPE Net | 6,865 | 6,750 | 6,625 | 6,408 | 6,285 |
| Other Non-Current Assets | 860 | 827 | 859 | 810 | 872 |
| TOTAL | $7,725 | $7,578 | $7,484 | $7,218 | $7,157 |
| Total Assets | $25,686 | $25,763 | $28,133 | $28,497 | $24,096 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 561 | 494 | 706 | 787 | 450 |
| Accrued Expenses | 426 | 481 | 247 | 633 | 342 |
| Other current liabilities | 0 | 0 | 0 | 11 | 0 |
| TOTAL | $988 | $1,303 | $1,603 | $2,251 | $871 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $310 | $307 | $330 |
| Total Liabilities | $988 | $1,303 | $1,913 | $2,558 | $1,201 |
| Shareholders' Equity | |||||
| Common Shares | 57 | 56 | 34 | 33 | 33 |
| Retained earnings | 2,177 | 1,945 | 7,719 | 7,643 | 5,589 |
| TOTAL | $24,698 | $24,460 | $26,220 | $25,939 | $22,895 |
| Total Liabilities And Equity | $25,686 | $25,763 | $28,133 | $28,497 | $24,096 |